Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Fosun to buy KKR-backed Indian drugmaker for up to $1.3 billion

Shanghai Fosun Pharmaceutical Group Co. Ltd. has agreed to buy an 86 percent stake in Gland Pharma – backed by KKR & Co. LP – for up to $1.3 billion, the largest acquisition of an Indian company from abroad in 2016.

Read More »

Boston Scientific’s sales beat on demand for heart devices

Boston Scientific Corp. reported better-than-expected quarterly sales as it sold more of its heart devices and revenue from its troubled cardiac rhythm management business increased.

Read More »

Future Eli Lilly CEO Says Dealmaking Will Be a Focus

Beginning in 2017, drugmaker Eli Lilly will have an increased focus on dealmaking under the leadership of its incoming chief executive officer David Ricks, Reuters reported.

Read More »

AstraZeneca Kills Six Pipeline Programs

Along with its dismal half-year financial reports, UK-based AstraZeneca announced it was halting six pipeline programs.

Read More »

Lack of exercise costs world $67.5 billion and 5 million lives a year

A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that.

Read More »

Ice Bucket Challenge credited with ALS breakthrough

The Ice Bucket Challenge that went viral two years ago – raising hundreds of millions of dollars – has helped identify a new gene behind the neurodegenerative disease ALS, or Lou Gehrig’s disease, researchers say.

Read More »

Alzheimer’s drug fails in study; some benefit seen

TauRx Pharmaceuticals’ experimental Alzheimer’s drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer’s disease.

Read More »

Anthem vows to fight for Cigna deal; profit beats estimates

Health insurer Anthem Inc. said it was committed to its planned acquisition of Cigna Corp. and again vowed to fight U.S. government efforts to block the deal, saying the merger will help lower costs for consumers.

Read More »

IBM steps up efforts in fight against Zika

International Business Machines Corp. said it would provide its technology and resources to help track the spread of the Zika virus.

Read More »

GSK chases next biotech asthma drug with $230 million J&J deal

GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom